alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                   Exhibit 10.19

                               DAVOX CORPORATION

                      PRESIDENT & CHIEF EXECUTIVE OFFICER

                              SEVERANCE AGREEMENT


  Davox Corporation ("Davox") will extend to you a severance package such that,
  in the event of your termination from employment for reasons other than for
  non- performance or in the event there is a change in control of the company
  that results in the loss of your job, demotion of your title, change in
  responsibilities or relocation of the company by more than seventy-five (75)
  miles, you will receive compensation at the rate equal to your current base
  salary in effect at the time of such termination, plus an amount equal to the
  actual earned bonus paid during the previous twelve months from the date of
  such termination. In addition, this severance package will provide you with
  medical / dental benefits continuation coverage consistent with that in effect
  at the time of such termination for a period of twelve months from the date of
  separation from employment.  These payments will be payable for a period of
  twelve months from the date of separation from employment, provided however
  such payments will cease immediately upon your employment with a Davox
  competitor.

Following the effective date of termination, as set forth in writing and
furnished to you by Davox, your employment with Davox shall cease and you shall
not hold yourself as an employee, agent, or representative of Davox.

Continuation of salary and benefits shall further be subject to your compliance
with any then existing company policies and such other terms as may be in effect
between you and Davox pertaining to the disclosure of confidential or
proprietary information.

Davox has final authority to determine all questions of eligibility to receive
benefits under this arrangement and to interpret and construe the terms of this
arrangement.


Approval:


          /s/ James D. Foy                        September 4, 2001
          ----------------                        -----------------
          President & Chief Executive Officer     Date


          /s/ Alphonse M. Lucchese                September 4, 2001
          ------------------------                -----------------
          Chairman of the Board                   Date
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         November 14, 2024.                    

# FOR FURTHER INFORMATION CONTACT:

Sean C. Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on October 30, 2024, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail Express, Priority Mail & USPS Ground Advantage® Contract 582 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2025-221, K2025-219.                

Sean C. Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2024-26337 Filed 11-13-24; 8:45 am]

BILLING CODE 7710-12-P
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 892 Introduced in Senate (IS)]

106th CONGRESS
  1st Session
                                 S. 892

 To amend the Internal Revenue Code of 1986 to permanently extend the 
            subpart F exemption for active financing income.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 27, 1999

Mr. Hatch (for himself, Mr. Baucus, Mr. Mack, Mr. Bryan, Mr. Murkowski, 
and Mr. Breaux) introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to permanently extend the 
            subpart F exemption for active financing income.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PERMANENT SUBPART F EXEMPTION FOR ACTIVE FINANCING INCOME.

    (a) Banking, Financing, or Similar Businesses.--Subsection (h) of 
section 954 of the Internal Revenue Code of 1986 (relating to special 
rule for income derived in the active conduct of banking, financing, or 
similar businesses) is amended by striking paragraph (9).
    (b) Insurance Businesses.--Subsection (a) of section 953 of such 
Code (defining insurance income) is amended by striking paragraph (10) 
and by redesignating paragraph (11) as paragraph (10).
    (c) Effective Date.--The amendments made by this section shall 
apply to taxable years of a foreign corporation beginning after 
December 31, 1998, and to taxable years of United States shareholders 
with or within which such taxable years of such foreign corporation 
end.
                                 <all>
```
Order entered March 26, 2013

In The 

## Court of Appeals **Fifth District of Texas at Dallas** No. 05 - 13 - 00039 - CV THE CITY OF DALLAS, Appellant V. THOMAS A. DAVENPORT, Appellee On Appeal from the 192nd Judicial District Court Dallas County, Texas Trial Co urt Cause No. DC - 11 - 09411 - K 

### O RDER The Court has before it appellee’s March 21, 2013 unopposed motion for extension of time to file his brief. The Court GRANTS the motion and ORDERS that appellee’s brief be filed by April 25, 2013.

/s/ ELIZABETH LANG

- MIE RS JUSTICE
T. O., A Child

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 1 6

- 15 7 3

_________ ____________________/

Opinion filed November 9, 2016.

An appeal from the Circuit Court for Duval C ounty

. Henry E . Davis

, J udge

.

Nancy A. Daniels, Public Defender, and S teven Seliger, Assistant Publi c Defender,

Tallahassee

, for Appellant

.

Pamela Jo Bond i, Attorney General, and Sharon S. Traxler, Assistant Attorney

General, Tallahassee , for Appellee.

PER CURIAM.

AFFIRMED.

RAY, KELSEY, and WINOKUR, JJ., CONCUR.
Docket No: FAA-2016-0733 Directorate ID: 2015-SW-040-AD Originating Office Tracking No.: ' Disposition Comments

Next Step: 1>!1 FRAN 0 NPRM D These comments are in response to an SNPRM 

### 0 No Comments/Only Supportiv Comments Received- {[this box is checked, 110 signatllres are required. 

# l No Has the referenced s rvicc information been revised since the NPRM was issued? 

### Ifyes. list latest rcvif,ion and attach 

### acopy. Note that changes beyondthe scope of tile

**J~re\'io~ls~v pub~islled** 

### 111 :R1Hwill require a new notice. Contact tile Directorate fuca/point for gmdance. .,.·..·, ·., · · Instructions: Summarize all comments 

### by issue (not by commenter) and provide your recommended resolution of each issue. All comments relating to the same issue should be discussed together. Do not list all ofthe issues from one commentertogether. lfchangds to the AD are required based on the comments received. explain why and describe in detail what change(s) you

**re~omrnend.** Reference FAA-IR-M-8040.\C Chapter 9. ISSUE 1: Select one oflhefo!lowil :applicability 

### ff

other. explain: Commenter(s): Robinson Hclicopte Company What change to the AD action is req tested? in (a) Applicability: Change "...part number (PIN) C016-7 Revision N/C. A through -·and AA through AE installed:...." to "...pat1numbcr (PIN)

**COI6~7** Revision AA through AE installed:...." Why is the change requested or how s itjustilied? Reason(s): \.Main rotor blade part number C016-7 did not exist until Revisio AA. and 2. Feedback from tield indicates some technicians have erroneously focused on Revi ion letters when complying with referenced R44 Service Bulletin 

### SB-89. and may likewise wrongfully apply the proposed AD to main rotor blade part number CO 16-5 Revisions 

### Wthru 

### Z. Do we agree? Yes IfYES, we agree because as Ro inson stated. part number COI6-7 did not exist until revision AA. Make the following changes t the AD: in (a) Applicability: Change "...part number (PIN) C016-7 Revision N/C. A though 

### Z. and AA through AE installed:...." to "...part number (PIN)

**C016~7** Revision AA through AE installed:...."

Page I of2SignatureSection Signature indicates concurrence with this action. Originating Office Tracking No.: ASE 

# L?U:#

Branch Manager 

# '6)JJ)J6 Date



### Page 2of2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Consumer Product Safety Commission

# TIME AND DATE:

Tuesday, October 29, 2024—9 a.m.

# PLACE:

Meeting will be at 4330 East West Highway, Bethesda, Maryland, Room 420.

# STATUS:

Commission Meeting—Closed to the Public.

# MATTERS TO BE CONSIDERED:

*Meeting Matter:*                         Briefing Matter.                    

# CONTACT PERSON FOR MORE INFORMATION: 

Alberta E. Mills, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814, 301-504-7479 (Office) or 240-863-8938 (Cell).

Dated: October 22, 2024.

Alberta Mills,

Commission Secretary.

[FR Doc. 2024-24950 Filed 10-23-24; 11:15 am]

BILLING CODE 6355-01-P
<PAGE>
                                                                 EXHIBIT 99 (ii)


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


IN CONNECTION WITH THE QUARTERLY REPORT OF FREDERICK BREWING CO. (THE "COMPANY")
ON FORM 10-QSB FOR THE PERIOD ENDED JUNE 30, 2002 AS FILED WITH THE SECURITIES
AND EXCHANGE COMMISSION ON THE DATE HEREOF (THE "REPORT"), I, DONALD L. SNYDER,
PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER OF THE COMPANY, CERTIFY, PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002, THAT:

     (1)  THE REPORT FULLY COMPLIES WITH THE REQUIREMENTS OF SECTION 13(a) OR
          15(d) OF THE SECURITIES EXCHANGE ACT OF 1934; AND

     (2)  THE INFORMATION CONTAINED IN THE REPORT FAIRLY PRESENTS, IN ALL
          MATERIAL RESPECTS, THE FINANCIAL CONDITION AND RESULTS OF OPERATIONS
          OF THE COMPANY.




/S/ DONALD L. SNYDER

DONALD L. SNYDER
PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
AUGUST 14, 2002
Exhibit 10.2


 


THIRD AMENDMENT


TO


NOTE AND WARRANT PURCHASE AGREEMENT


 


THIS THIRD AMENDMENT TO NOTE AND
WARRANT PURCHASE AGREEMENT (this
“Amendment”) is made and entered into as of October 5, 2010 by and
between TECHNISCAN, INC., (the “Issuer”)
and BIOTEX PHARMA INVESTMENTS, LLC (the “Lead
Investor”).


 


R  E  C  I  T  A
L  S:


 


WHEREAS,
the Issuer and the Lead Investor desire to revise that certain Note and Warrant
Purchase Agreement dated March 30, 2010 entered into by and among the
Issuer, the Lead Investor, and the other investors listed on Exhibit A
thereto, as amended pursuant to that certain Amendment to Note and Warrant
Purchase Agreement dated as of May 19, 2010 and that certain Second
Amendment to Note and Warrant Purchase Agreement dated as of September 30,
2010 (collectively, the “Agreement”).


 


NOW, THEREFORE, in consideration of the foregoing and the mutual benefits
to be derived from this Amendment, the parties hereto hereby agree as follows:


 


1.            Amendment
of the Agreement.  Pursuant to Section 7.3
of the Agreement, Section 3.2 of the Agreement is hereby amended as
follows:


 


The date October 8, 2010 shall be
deleted and replaced with October 14, 2010.


 


2.            Continued
Effect of the Agreement.  All
provisions of the Agreement, except as modified by this Amendment, shall remain
in full force and effect and are reaffirmed. 
Other than as stated in this Amendment, this Amendment shall not operate
as a waiver of any condition or obligation imposed on the parties under the Agreement.


 


3.            Interpretation
of Amendment.  In the event of any
conflict, inconsistency, or incongruity between any provision of this Amendment
and any provision of the Agreement, the provisions of this Amendment shall
govern and control.


 


4.             Counterparts.  This Amendment may be executed in any number
of counterparts, each of which shall be deemed an original, and all of which
together shall constitute one and the same agreement.  A facsimile or e-mailed “.pdf” data file copy
of an original written signature shall be deemed to have the same effect as an
original written signature.


 


IN WITNESS
WHEREOF, the parties hereto have
executed this Amendment to Registration Rights Agreement as of the date first
set forth above.


 


	
  TECHNISCAN, INC.

  	
   

  	
  BIOTEX PHARMA INVESTMENTS, LLC

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  By:

  	
  /s/ David C. Robinson

  	
   

  	
   

  	
  By:

  	
  /s/ Robert Kessler

  
	
  David C. Robinson

  	
   

  	
   

  	
  Robert Kessler

  
	
  Chief Executive Officer

  	
   

  	
   

  	
  Member
<TABLE> <S> <C>

<ARTICLE> 9
<RESTATED>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                      1,332,521
<INT-BEARING-DEPOSITS>                        894,485
<FED-FUNDS-SOLD>                                    0
<TRADING-ASSETS>                                    0
<INVESTMENTS-HELD-FOR-SALE>                 2,030,730
<INVESTMENTS-CARRYING>                      3,443,266
<INVESTMENTS-MARKET>                        3,443,266
<LOANS>                                    53,537,887
<ALLOWANCE>                                   165,309
<TOTAL-ASSETS>                             64,312,981
<DEPOSITS>                                 52,676,645
<SHORT-TERM>                                3,000,000
<LIABILITIES-OTHER>                         1,195,941
<LONG-TERM>                                         0
<COMMON>                                        4,702
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<OTHER-SE>                                  7,440,395
<TOTAL-LIABILITIES-AND-EQUITY>             64,312,981
<INTEREST-LOAN>                             1,154,840
<INTEREST-INVEST>                              73,323
<INTEREST-OTHER>                               32,562
<INTEREST-TOTAL>                            1,260,725
<INTEREST-DEPOSIT>                            592,384
<INTEREST-EXPENSE>                            617,316
<INTEREST-INCOME-NET>                         643,409
<LOAN-LOSSES>                                  30,500
<SECURITIES-GAINS>                                  0
<EXPENSE-OTHER>                               104,407
<INCOME-PRETAX>                               301,544
<INCOME-PRE-EXTRAORDINARY>                    301,544
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                  168,085
<EPS-PRIMARY>                                     .44 <F1>
<EPS-DILUTED>                                     .55 <F1>
<YIELD-ACTUAL>                                   4.27
<LOANS-NON>                                   699,000
<LOANS-PAST>                                  144,000
<LOANS-TROUBLED>                                    0
<LOANS-PROBLEM>                                     0
<ALLOWANCE-OPEN>                              147,645
<CHARGE-OFFS>                                  19,535 
<RECOVERIES>                                    6,738
<ALLOWANCE-CLOSE>                             165,309
<ALLOWANCE-DOMESTIC>                          165,309
<ALLOWANCE-FOREIGN>                                 0
<ALLOWANCE-UNALLOCATED>                             0
<FN>
<F1>  Restated for adoption of SFAS No. 128.
        

</TABLE>
Exhibit
31.2





EQUITY
GENERAL PARTNER CERTIFICATION


PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002





I, Robert
McKinney, certify that:





1. I have
reviewed this quarterly report on Form 10-Q of National Property Analysts Master
Limited Partnership;





2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;





3. Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;





4. The
registrant's other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:





(a)
Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;





(b)
Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and





(c)
Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and





5. The
registrant's other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):





(a) All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and





(b) Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.





Date:
                May
      12, 2010By:
                Feldman International Inc., its equity general
      partnerBy:
                /s/ Robert McKinneyName:
                Robert
      McKinneyTitle:
                President
#### State, Respondent, vs. O’Leary, Appellant.

*April 12*

May *6, 1924.*

*Criminal law: Appeal: Writ of error.*

1. An appeal is a purely statutory proceeding, p. 49.

2. The supreme court has no jurisdiction to entertain appeals in criminal cases, the remedy being by writ of error as provided in sec. 4724, Stats, p. 49.

Appeal from an order of the municipal court of Rock county: H. L. Maxfield, Judge.

*Dismissed.*

This is an appeal from an order sustaining the state’s demurrer to defendant’s plea of former conviction.

The cause was submitted for the appellant on the brief of *Edzvard H. Ryan*of Janesville, and for the respondent on that of the *Attorney General*and /. *E. Messerschmidt,*assistant attorney general.

Crownhart, J.

.This is an attempted appeal in a criminal •cause, wherein the lower-court sustained the demurrer to defendant’s plea of former jeopardy. An appeal is a purely statutory proceeding. Thé statute makes no provision for appeal to this court in criminal cases. On the other hand, the practice for obtaining review in this court of proceedings in the lower courts in criminal cases is by writ of error as provided in sec. 4724, Stats. This court has no jurisdiction of this cause for the reasons stated. Therfefore the appeal should be dismissed.

*By the Court.*— The appeal from the order of the lower court is dismissed for lack of jurisdiction.